Indian equity benchmarks closed lower on Tuesday, June 17, 2025, as cautious market sentiment weighed on investor confidence. The BSE Sensex dropped 212.85 points (0.26%) to settle at 81,583.30, while the NSE Nifty 50 declined 93.10 points (0.37%), closing …

… to ₹335.35. Top Losers Sun Pharma slumped 2.18 per cent …

… to 21,622. Pharma major Sun Pharma saw its shares falling over …

… s Neutral call on Sun Pharma- Nomura on Sun Pharma: Limited financial upside from … Nomura on Sun Pharma: Management changes to help transition Also, Sun Pharma has elevated … immediate stock outperformance.  Nomura on Sun Pharma: Positives priced in already In …

… developments. These include Adani Enterprises, Sun Pharma, NTPC, Bajaj Finance, Vedanta, and … to the Middle East region. SUN PHARMA Sun Pharmaceutical confirmed that the …

… facility from June 2-13, Sun Pharma said in a filing to …

Indian equity markets closed on a strong note on June 16, 2025, with broad-based gains across major sectors. The BSE Sensex surged 677.55 points (0.84%) to close at 81,796.15, while the NSE Nifty 50 gained 227.90 points (0.92%) to end at 24,946.50—just shy …

… Form-483, with 8 observations,” Sun Pharma said in a regulatory filing … of the key plants for Sun Pharma but has been under an … plant. Earlier on June 13, Sun Pharma had announced a significant leadership … 3,716 crore.  Shares of Sun Pharma were down 0.56 per …

Shares of Sun Pharmaceutical Industries fell up to 2% to touch its intraday low of ₹1,655.70 on June 16, Monday following two announcements by the company over weekend. The company, on Saturday, announced that the US Food and Drug Administration has issued …

… consideration of Rs 400 crore. Sun Pharma: The USFDA conducted a Good …